Financials

News Discussions Technicals Forecast Seasonals

NWRN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEWRON PHARMA N operating, investing, and financing activities

NWRN free cash flow for H1 24 is -8.5 M CHF. For 2023, NWRN free cash flow was -9.86 M CHF and operating cash flow was -9.85 M CHF.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—